Brief: Santhera FY Net Loss Widens To CHF 67.7 Million
April 29 (Reuters) - Santhera Pharmaceuticals Holding AG
SANN.S :
* SANTHERA REPORTS 2020 ANNUAL RESULTS
* FY REVENUE FROM CONTRACTS WITH CUSTOMERS OF CHF 15.0
MILLION
* FY OPERATING RESULT OF CHF -53.1 MILLION (2019: CHF -10.4
MILLION) AND NET RESULT OF CHF -67.7 MILLION (2019: CHF -19.0
MILLION)
Source text for Eikon: ID:nGNE6bkMvy
Further company coverage: SANN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Santhera Pharmaceuticals Holding AG
See all newsSwitzerland's Santhera Pharma H1 revenue soars on AGAMREE sales, milestones
Brief: Santhera Pharmaceuticals H1 Operating Income CHF -6.562 Million
Brief: Santhera Says NXERA Plans To Submit South Korea Marketing Authorization Application 2026
Brief: Santhera Gets Positive CHMP Opinion To Expand Agamree (Vamorolone) Use
Brief: Santhera Pharmaceuticals H1 Operating Income CHF -35.444 Million